Literature DB >> 19819272

Negative symptoms of schizophrenia correlate with impairment on the University of Pennsylvania smell identification test.

Koko Ishizuka1, Katsunori Tajinda, Carlo Colantuoni, Masahiko Morita, Jessica Winicki, Cindy Le, Sandra Lin, David Schretlen, Akira Sawa, Nicola G Cascella.   

Abstract

Deficits in odor identification have been most frequently described in schizophrenia (SZ). A relationship between dysfunction in odor identification and negative symptoms of SZ has also been reported. Furthermore, deficit SZ (a subtype of the illness with primary, enduring negative symptoms) has been found to be associated with a particularly poor performance on odor identification tests indicating that deficits in smell identification could be differentially expressed in some subtypes of SZ. We describe correlations of performance on smell identification with positive and negative symptoms of SZ. Patients with SZ (n=15) and normal controls (n=19) were tested by the University of Pennsylvania Smell Identification Test (UPSIT). Psychopathology was assessed with the Scales for the Assessment of Positive and Negative Symptoms (SAPS and SANS). SZ patients performed more poorly on the UPSIT test than did normal controls. Consistent with previous findings, we observed a correlation of SANS with UPSIT performance. In particular, specific subdomains of SANS, such as blunted affect, apathy and anhedonia, were associated with odor identification deficits. Furthermore, UPSIT score predicts these subdomains of negative symptoms. No correlation was observed between positive symptom and odor identification deficits. Our study further reinforces a relation between olfactory identification deficit and negative symptoms in SZ and suggests that smell identification could be a candidate endophenotype relevant to negative symptoms of SZ. Copyright 2009 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19819272      PMCID: PMC4064297          DOI: 10.1016/j.neures.2009.10.001

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  41 in total

Review 1.  Advances in schizophrenia.

Authors:  G K Thaker; W T Carpenter
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

2.  Olfactory impairment in monozygotic twins discordant for schizophrenia.

Authors:  Tarik Ugur; Matthias Weisbrod; Ernst Franzek; Ute Pfüller; Heinrich Sauer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-12       Impact factor: 5.270

3.  Olfactory identification deficits in first-episode psychosis may predict patients at risk for persistent negative and disorganized or cognitive symptoms.

Authors:  Kimberley P Good; David Whitehorn; Qing Rui; Heather Milliken; Lili C Kopala
Journal:  Am J Psychiatry       Date:  2006-05       Impact factor: 18.112

4.  Olfactory functioning in schizophrenia: relationship to clinical, neuropsychological, and volumetric MRI measures.

Authors:  Paul J Moberg; Steven E Arnold; Richard L Doty; Raquel E Gur; Catherine C Balderston; David R Roalf; Ruben C Gur; Christian G Kohler; Stephen J Kanes; Steven J Siegel; Bruce I Turetsky
Journal:  J Clin Exp Neuropsychol       Date:  2006-11       Impact factor: 2.475

5.  Dysregulation of olfactory receptor neuron lineage in schizophrenia.

Authors:  S E Arnold; L Y Han; P J Moberg; B I Turetsky; R E Gur; J Q Trojanowski; C G Hahn
Journal:  Arch Gen Psychiatry       Date:  2001-09

6.  Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses.

Authors:  Richard D McCurdy; François Féron; Chris Perry; David C Chant; Duncan McLean; Nick Matigian; Nicholas K Hayward; John J McGrath; Alan Mackay-Sim
Journal:  Schizophr Res       Date:  2006-01-06       Impact factor: 4.939

7.  Human olfactory epithelial cells generated in vitro express diverse neuronal characteristics.

Authors:  K E Borgmann-Winter; N E Rawson; H-Y Wang; H Wang; M L Macdonald; M H Ozdener; K K Yee; G Gomez; J Xu; B Bryant; G Adamek; N Mirza; E Pribitkin; C-G Hahn
Journal:  Neuroscience       Date:  2008-10-17       Impact factor: 3.590

8.  Odor identification impairments in schizophrenia: relationship with demographic measures, clinical variables, and diagnostic subtypes.

Authors:  Eliza Coleman; Raymond R Goetz; David Leitman; Scott Yale; Ariel Stanford; Jack M Gorman; Dolores Malaspina
Journal:  CNS Spectr       Date:  2002-01       Impact factor: 3.790

9.  Olfactory hedonic judgment in patients with deficit syndrome schizophrenia.

Authors:  Gregory P Strauss; Daniel N Allen; Sylvia A Ross; Lisa A Duke; Jason Schwartz
Journal:  Schizophr Bull       Date:  2009-02-17       Impact factor: 9.306

Review 10.  Cellular and molecular neuropathology of the olfactory epithelium and central olfactory pathways in Alzheimer's disease and schizophrenia.

Authors:  S E Arnold; G S Smutzer; J Q Trojanowski; P J Moberg
Journal:  Ann N Y Acad Sci       Date:  1998-11-30       Impact factor: 5.691

View more
  22 in total

1.  Effects of the val(158)met catechol-O-methyltransferase gene polymorphism on olfactory processing in schizophrenia.

Authors:  Vidyulata Kamath; Paul J Moberg; Raquel E Gur; Richard L Doty; Bruce I Turetsky
Journal:  Behav Neurosci       Date:  2011-12-12       Impact factor: 1.912

2.  Detection of intergenerational genetic effects with application to HLA-B matching as a risk factor for schizophrenia.

Authors:  Erica J Childs; Eric M Sobel; Christina G S Palmer; Janet S Sinsheimer
Journal:  Hum Hered       Date:  2011-10-15       Impact factor: 0.444

3.  Smell identification in individuals at clinical high risk for schizophrenia.

Authors:  Kelly Elizabeth Gill; Elizabeth Evans; Jürgen Kayser; Shelly Ben-David; Julie Messinger; Gerard Bruder; Dolores Malaspina; Cheryl Mary Corcoran
Journal:  Psychiatry Res       Date:  2014-07-17       Impact factor: 3.222

Review 4.  Application of olfactory tissue and its neural progenitors to schizophrenia and psychiatric research.

Authors:  Joëlle Lavoie; Akira Sawa; Koko Ishizuka
Journal:  Curr Opin Psychiatry       Date:  2017-05       Impact factor: 4.741

5.  MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients.

Authors:  Eyal Mor; Shin-Ichi Kano; Carlo Colantuoni; Akira Sawa; Ruth Navon; Noam Shomron
Journal:  Neurobiol Dis       Date:  2013-03-29       Impact factor: 5.996

6.  Identification of pleasant, neutral, and unpleasant odors in schizophrenia.

Authors:  Vidyulata Kamath; Bruce I Turetsky; Paul J Moberg
Journal:  Psychiatry Res       Date:  2011-01-15       Impact factor: 3.222

7.  Olfactory performance segregates effects of anhedonia and anxiety on social function in patients with schizophrenia.

Authors:  Kristina Cieslak; Julie Walsh-Messinger; Arielle Stanford; Leila Vaez-Azizi; Daniel Antonius; Jill Harkavy-Friedman; Deborah Goetz; Raymond R Goetz; Dolores Malaspina
Journal:  J Psychiatry Neurosci       Date:  2015-11       Impact factor: 6.186

8.  Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study.

Authors:  Mary R Lee; Heidi J Wehring; Robert P McMahon; Jared Linthicum; Nicola Cascella; Fang Liu; Alan Bellack; Robert W Buchanan; Gregory P Strauss; Carlo Contoreggi; Deanna L Kelly
Journal:  Schizophr Res       Date:  2013-02-13       Impact factor: 4.939

9.  Kallmann syndrome and paranoid schizophrenia: a rare combination.

Authors:  Willem M A Verhoeven; Jos I M Egger; Johannes E Hovens; Lies Hoefsloot
Journal:  BMJ Case Rep       Date:  2013-01-17

10.  Olfactory deficits in individuals at risk for psychosis and patients with schizophrenia: relationship with socio-cognitive functions and symptom severity.

Authors:  Tsutomu Takahashi; Mihoko Nakamura; Daiki Sasabayashi; Yuko Komori; Yuko Higuchi; Yumiko Nishikawa; Shimako Nishiyama; Hiroko Itoh; Yuri Masaoka; Michio Suzuki
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-10-25       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.